Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 .
|
... HIV-1 infection. Secondary objectives included
immunogenicity and effects on viral rebound kinetics during a 24-week
antiretroviral treatment ... |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...